课题基金 / 基金详情

EFFECT OF FOUR DRUG/DOUBLE PROTEASE INHIBITOR THERAPY IN HIV PATIENTS

EFFECT OF FOUR DRUG/DOUBLE PROTEASE INHIBITOR THERAPY IN HIV PATIENTS
四种药物/双蛋白酶抑制剂治疗 HIV 患者的效果
批准号:
6219363
负责人:
THOMAS C MERIGAN
金额:
$0.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

THOMAS C MERIGAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the efficacy of a four drug regimen containing two protease inhibitors, Saquinavir Soft Gel Capsule and Nelfinavir, plus two reverse transcriptase inhibitor on the complete suppression of HIV-1 viral replication in antiretroviral naive patients and as salvage regimen in Indinavir experience patients. To determine how compliance and measures of drug exposure influence the response to therapy, and to understand possible mechanisms of therapeutic failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV-1 CO-INFECTED SUBJECTS
  • 批准号:
    7605200
  • 项目类别:
  • 资助金额:
    $4.74万
  • 财政年份:
    2007
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
  • 批准号:
    7605165
  • 项目类别:
  • 资助金额:
    $2.09万
  • 财政年份:
    2007
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
  • 批准号:
    7605184
  • 项目类别:
  • 资助金额:
    $0.38万
  • 财政年份:
    2007
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
  • 批准号:
    7375261
  • 项目类别:
  • 资助金额:
    $6.32万
  • 财政年份:
    2005
  • 负责人:
    THOMAS C MERIGAN
  • 依托单位:
海外基金